November 10, 2025 - 18:53

MENLO PARK, Calif., November 10, 2025—Octave Bioscience, Inc., a pioneer in precision care for managing multiple sclerosis (MS) and other neurodegenerative diseases, has announced its participation in the upcoming Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum. The event is scheduled for Thursday, November 20, 2025, at 9:00 AM EST and will take place at The Westin Grand Central in New York, NY.
The management team from Octave Bioscience will engage in a panel discussion that aims to highlight advancements in the field of neurodegenerative disease management. This forum serves as a significant platform for industry leaders to share insights, discuss emerging trends, and explore innovative solutions that can improve patient outcomes.
As the healthcare landscape continues to evolve, Octave Bioscience remains committed to delivering cutting-edge solutions and fostering collaboration within the MedTech community. The company's participation underscores its dedication to advancing the understanding and treatment of MS and related conditions.
April 7, 2026 - 04:57
Doctors warn that Israel is targeting Lebanon's health care system, as it did Gaza'sSince the war between Israel and the militant group Hezbollah reignited, hostilities have pushed deeper into southern Lebanon. Medical professionals and international observers are now issuing...
April 6, 2026 - 04:00
Suspected measles outbreak kills nearly 100 children in BangladeshA devastating suspected measles outbreak is sweeping through northern Bangladesh, with the national health ministry reporting that nearly 100 children have lost their lives. The situation is...
April 5, 2026 - 11:58
Plans for Jersey's wealthy to pay UK health costs axedA contentious proposal requiring Jersey`s wealthiest residents to directly pay for their National Health Service (NH) treatment in the UK has been formally abandoned. The scheme, which had been...
April 4, 2026 - 21:29
Future of healthcare: Could AI someday replace doctors?The rapid integration of artificial intelligence into medical diagnostics and treatment planning is sparking a profound debate within the healthcare industry. While AI demonstrates remarkable...